SHUFRO ROSE & CO LLC - IMMUCELL CORP ownership

IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 27 filers reported holding IMMUCELL CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SHUFRO ROSE & CO LLC ownership history of IMMUCELL CORP
ValueSharesWeighting
Q3 2023$333,253
+6.8%
62,4080.0%0.03%
+10.7%
Q2 2023$312,040
-2.2%
62,4080.0%0.03%
-6.7%
Q1 2023$318,905
-16.2%
62,4080.0%0.03%
-6.2%
Q4 2022$380,689
-18.5%
62,4080.0%0.03%
-31.9%
Q3 2022$467,000
-34.5%
62,408
-23.9%
0.05%
-24.2%
Q2 2022$713,000
-10.0%
82,037
-0.0%
0.06%
+1.6%
Q1 2022$792,000
+453.8%
82,046
+358.1%
0.06%
+510.0%
Q4 2021$143,000
-14.9%
17,9090.0%0.01%
-23.1%
Q3 2021$168,000
-1.2%
17,9090.0%0.01%0.0%
Q2 2021$170,000
-1.7%
17,9090.0%0.01%
-7.1%
Q1 2021$173,000
-42.5%
17,909
-64.7%
0.01%
-44.0%
Q4 2020$301,000
+9.5%
50,6700.0%0.02%
-3.8%
Q3 2020$275,000
+14.6%
50,6700.0%0.03%
+8.3%
Q2 2020$240,000
+25.0%
50,6700.0%0.02%
+4.3%
Q1 2020$192,000
-26.4%
50,6700.0%0.02%
-4.2%
Q4 2019$261,000
-7.4%
50,6700.0%0.02%
-14.3%
Q3 2019$282,000
-14.3%
50,6700.0%0.03%
-12.5%
Q2 2019$329,000
+2.2%
50,6700.0%0.03%0.0%
Q1 2019$322,000
-9.8%
50,6700.0%0.03%
-17.9%
Q4 2018$357,000
-15.6%
50,670
-0.2%
0.04%0.0%
Q3 2018$423,000
+27.0%
50,791
+4.1%
0.04%
+21.9%
Q2 2018$333,000
-2.6%
48,7910.0%0.03%
-5.9%
Q1 2018$342,000
-20.3%
48,7910.0%0.03%
-19.0%
Q4 2017$429,000
+32.4%
48,791
-2.0%
0.04%
+27.3%
Q3 2017$324,0000.0%49,791
+12.7%
0.03%
-5.7%
Q2 2017$324,000
+32.8%
44,1910.0%0.04%
+34.6%
Q1 2017$244,000
-7.2%
44,1910.0%0.03%
-10.3%
Q4 2016$263,000
-23.1%
44,1910.0%0.03%
-23.7%
Q3 2016$342,000
+17.5%
44,191
+4.7%
0.04%
+18.8%
Q2 2016$291,000
+0.7%
42,1910.0%0.03%0.0%
Q1 2016$289,000
-2.7%
42,191
+5.0%
0.03%
-5.9%
Q4 2015$297,000
+24.3%
40,1910.0%0.03%
+17.2%
Q3 2015$239,000
-38.4%
40,191
-18.8%
0.03%
-29.3%
Q2 2015$388,000
+21.2%
49,468
-2.9%
0.04%
+24.2%
Q1 2015$320,000
+24.5%
50,968
-3.8%
0.03%
+26.9%
Q4 2014$257,000
-2.3%
52,9680.0%0.03%
-3.7%
Q3 2014$263,000
+12.9%
52,9680.0%0.03%
+12.5%
Q2 2014$233,000
-6.0%
52,968
+2.1%
0.02%
-7.7%
Q1 2014$248,000
+12.2%
51,8630.0%0.03%
+13.0%
Q4 2013$221,000
-9.8%
51,8630.0%0.02%
-17.9%
Q3 2013$245,000
+27.6%
51,863
+1.2%
0.03%
+21.7%
Q2 2013$192,000
-26.2%
51,263
+0.6%
0.02%
-32.4%
Q3 2012$260,00050,9630.03%
Other shareholders
IMMUCELL CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Bleichroeder LP 101,594$619,7230.14%
PERRITT CAPITAL MANAGEMENT INC 30,000$183,0000.10%
Overbrook Management Corp 35,532$216,7450.06%
WEALTH EFFECTS LLC 15,650$95,4650.05%
Minerva Advisors LLC 11,958$720.05%
SHUFRO ROSE & CO LLC 62,408$380,6890.03%
Strategic Financial Services, Inc, 31,000$189,7200.02%
FLAGSHIP HARBOR ADVISORS, LLC 14,230$86,8030.01%
Essex Financial Services, Inc. 11,000$670.01%
Renaissance Technologies 125,489$7650.00%
View complete list of IMMUCELL CORP shareholders